Annual Cash & Cash Equivalents
$704.20 M
+$30.00 M+4.45%
31 December 2023
Summary:
Insulet annual cash & cash equivalents is currently $704.20 million, with the most recent change of +$30.00 million (+4.45%) on 31 December 2023. During the last 3 years, it has fallen by -$203.00 million (-22.38%). PODD annual cash & cash equivalents is now -22.38% below its all-time high of $907.20 million, reached on 31 December 2020.PODD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$902.60 M
+$81.60 M+9.94%
30 September 2024
Summary:
Insulet quarterly cash and cash equivalents is currently $902.60 million, with the most recent change of +$81.60 million (+9.94%) on 30 September 2024. Over the past year, it has increased by +$232.80 million (+34.76%). PODD quarterly cash and cash equivalents is now -0.51% below its all-time high of $907.20 million, reached on 31 December 2020.PODD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PODD Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.5% | +34.8% |
3 y3 years | -22.4% | +5.7% |
5 y5 years | +518.3% | +115.0% |
PODD Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -22.4% | +4.5% | at high | +45.4% |
5 y | 5 years | -22.4% | +518.3% | -0.5% | +354.7% |
alltime | all time | -22.4% | >+9999.0% | -0.5% | >+9999.0% |
Insulet Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $902.60 M(+9.9%) |
June 2024 | - | $821.00 M(+9.3%) |
Mar 2024 | - | $751.20 M(+6.7%) |
Dec 2023 | $704.20 M(+4.4%) | $704.20 M(+5.1%) |
Sept 2023 | - | $669.80 M(+3.9%) |
June 2023 | - | $644.70 M(+3.9%) |
Mar 2023 | - | $620.70 M(-7.9%) |
Dec 2022 | $674.20 M(-14.7%) | $674.20 M(-6.6%) |
Sept 2022 | - | $721.50 M(+2.0%) |
June 2022 | - | $707.40 M(-0.2%) |
Mar 2022 | - | $708.50 M(-10.3%) |
Dec 2021 | $790.00 M(-12.9%) | $790.00 M(-7.5%) |
Sept 2021 | - | $853.70 M(+0.2%) |
June 2021 | - | $851.80 M(+4.1%) |
Mar 2021 | - | $817.90 M(-9.8%) |
Dec 2020 | $907.20 M(+324.5%) | $907.20 M(+8.7%) |
Sept 2020 | - | $834.30 M(+7.5%) |
June 2020 | - | $776.20 M(+291.0%) |
Mar 2020 | - | $198.50 M(-7.1%) |
Dec 2019 | $213.70 M(+87.6%) | $213.70 M(-49.1%) |
Sept 2019 | - | $419.88 M(+250.3%) |
June 2019 | - | $119.87 M(-7.3%) |
Mar 2019 | - | $129.25 M(+13.5%) |
Dec 2018 | $113.90 M(-58.2%) | $113.90 M(-10.0%) |
Sept 2018 | - | $126.56 M(-7.1%) |
June 2018 | - | $136.25 M(-32.9%) |
Mar 2018 | - | $203.15 M(-25.5%) |
Dec 2017 | $272.58 M(+98.7%) | $272.58 M(+166.6%) |
Sept 2017 | - | $102.23 M(+39.1%) |
June 2017 | - | $73.49 M(-3.4%) |
Mar 2017 | - | $76.04 M(-44.6%) |
Dec 2016 | $137.17 M(+11.8%) | $137.17 M(-36.3%) |
Sept 2016 | - | $215.40 M(+184.7%) |
June 2016 | - | $75.66 M(-32.2%) |
Mar 2016 | - | $111.64 M(-9.0%) |
Dec 2015 | $122.67 M | $122.67 M(-15.7%) |
Sept 2015 | - | $145.47 M(+0.2%) |
June 2015 | - | $145.14 M(-0.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | $145.61 M(-3.7%) |
Dec 2014 | $151.19 M(+1.0%) | $151.19 M(+3.3%) |
Sept 2014 | - | $146.37 M(-16.6%) |
June 2014 | - | $175.54 M(+20.6%) |
Mar 2014 | - | $145.61 M(-2.7%) |
Dec 2013 | $149.73 M(+161.3%) | $149.73 M(-2.7%) |
Sept 2013 | - | $153.91 M(+2.0%) |
June 2013 | - | $150.94 M(+1.9%) |
Mar 2013 | - | $148.06 M(+158.4%) |
Dec 2012 | $57.29 M(-39.0%) | $57.29 M(-9.7%) |
Sept 2012 | - | $63.44 M(-9.6%) |
June 2012 | - | $70.14 M(-15.5%) |
Mar 2012 | - | $83.01 M(-11.7%) |
Dec 2011 | $93.95 M(-17.1%) | $93.95 M(-9.5%) |
Sept 2011 | - | $103.81 M(-2.7%) |
June 2011 | - | $106.75 M(+2.2%) |
Mar 2011 | - | $104.49 M(-7.8%) |
Dec 2010 | $113.27 M(-11.5%) | $113.27 M(+9.0%) |
Sept 2010 | - | $103.92 M(-12.0%) |
June 2010 | - | $118.07 M(-0.2%) |
Mar 2010 | - | $118.34 M(-7.5%) |
Dec 2009 | $128.00 M(+125.9%) | $128.00 M(+76.1%) |
Sept 2009 | - | $72.69 M(+38.8%) |
June 2009 | - | $52.36 M(-23.2%) |
Mar 2009 | - | $68.16 M(+20.3%) |
Dec 2008 | $56.66 M(-40.1%) | $56.66 M(-23.6%) |
Sept 2008 | - | $74.13 M(-25.2%) |
June 2008 | - | $99.11 M(+35.7%) |
Mar 2008 | - | $73.03 M(-22.8%) |
Dec 2007 | $94.59 M(+184.6%) | $94.59 M(-9.2%) |
Sept 2007 | - | $104.21 M(-13.0%) |
June 2007 | - | $119.82 M(+528.1%) |
Mar 2007 | - | $19.08 M(-42.6%) |
Dec 2006 | $33.23 M(+333.8%) | $33.23 M(+32.4%) |
Sept 2006 | - | $25.09 M(+227.5%) |
Dec 2005 | $7.66 M(-68.1%) | $7.66 M |
Dec 2004 | $24.00 M(+454.5%) | - |
Dec 2003 | $4.33 M(-74.5%) | - |
Dec 2002 | $16.96 M | - |
FAQ
- What is Insulet annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Insulet?
- What is Insulet annual cash & cash equivalents year-on-year change?
- What is Insulet quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Insulet?
- What is Insulet quarterly cash and cash equivalents year-on-year change?
What is Insulet annual cash & cash equivalents?
The current annual cash & cash equivalents of PODD is $704.20 M
What is the all time high annual cash & cash equivalents for Insulet?
Insulet all-time high annual cash & cash equivalents is $907.20 M
What is Insulet annual cash & cash equivalents year-on-year change?
Over the past year, PODD annual cash & cash equivalents has changed by +$30.00 M (+4.45%)
What is Insulet quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PODD is $902.60 M
What is the all time high quarterly cash and cash equivalents for Insulet?
Insulet all-time high quarterly cash and cash equivalents is $907.20 M
What is Insulet quarterly cash and cash equivalents year-on-year change?
Over the past year, PODD quarterly cash and cash equivalents has changed by +$232.80 M (+34.76%)